Caspian Tamin Pharmaceutical Co.

What Caspian Tamin Pharmaceutical Co. does

Caspian Tamin Pharmaceutical Co. is an Iranian publicly listed pharmaceutical manufacturer (public joint stock company) specializing in injectable pharmaceutical products. Founded in 1983 as Iran Pharmaceutical Development and Investment Company (IPDIC) and renamed Caspian Tamin, the company operates a 150,000 square-meter GMP- and WHO-compliant manufacturing facility in Rasht Industrial City, Gilan Province, with corporate headquarters in Tehran. It is controlled by Tamin Pharmaceutical Investment Company (TPICO), itself under the Social Security Investment Company (SSIC), giving it state-affiliated backing within a broader pharmaceutical investment group. The firm is described as the pharmaceutical hub of northern Iran and has received multiple national and provincial awards including repeated Top Exporter of Guilan Province recognition.

The company's product portfolio spans 13 therapeutic categories — analgesics/anti-inflammatories, antimyasthenic/muscle relaxants, hormonal/anabolic drugs, antihistamines/bronchodilators, cardiovascular/homeostatic agents, corticosteroids, antibacterials, gastrointestinal, antagonists, nutritional supplements/vitamins, dermatological, antifungals, and immunomodulators — delivered in ampoules, vials, prefilled syringes, syrups/oral solutions, suppositories, and topical creams/ointments/gels. Notable differentiated products include Casmeron (Rocuronium Bromide) for rapid sequence intubation, Sugammadex as the first Iranian-manufactured neuromuscular blockade reversal agent, and Caspiramer (Glatiramer Acetate) for relapsing forms of multiple sclerosis. Certifications include ISO 9001, ISO 14001, ISO 45001, ISO 10015, ISO 10002, ISO 10004, and GMP export certification for prefilled syringe and injection production lines.

Commercially, Caspian Tamin sells through a B2B distribution model anchored by board-level channel partners Daroupakhsh Co. and Pars Daru Company, reaching pharmacies, hospitals, and healthcare institutions across Iran. The company operates a dedicated export function with distribution in the Middle East, and engages healthcare providers through physician engagement, medical conferences, and a corporate website with shareholder portals. It does not publish pricing or revenue and employs approximately 84 staff; its go-to-market combines direct institutional supply with distribution-partner channels within a regulated domestic pricing environment.

Name

Caspian Tamin Pharmaceutical Co.

Legal name

Caspian Tamin Pharmaceutical Co.

Website

https://caspiantamin.com

Company type

Public

Founded year

1983

Operating status

Operating

Headcount range

51–100 employees

Short description

Caspian Tamin Pharmaceutical Co. is an Iranian public joint stock pharmaceutical manufacturer specializing in injectable products across 13 therapeutic categories, serving hospitals, pharmacies, and export markets via TPICO-affiliated distribution partners Daroupakhsh and Pars Daru.

Ownership category

akta.pro rank

Product category

Generic Pharmaceutical Manufacturing

NAICS

Pharmaceutical Preparation Manufacturing (325412)

SIC

Pharmaceutical Preparations (2834)

akta.pro primary industry

Pain Relief & Anti-Inflammatory (Analgesics) (HLAIADAA)

akta.pro secondary industry

Dermatology Specialty Pharmaceuticals (HLAIACAL)

Keywords

• Injectable pharmaceutical manufacturing
• Generic pharmaceutical products
• Muscle relaxant medications
• GMP-certified pharmaceutical production
• Pharmaceutical distribution networks

Headquarters

HQ city

Tehran

HQ country

Iran

HQ region

Middle East

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Operations, Personnel, Supply Chain, Infrastructure, Technology or R&D, Marketing or Sales

Revenue model

1. Pharmaceutical Product Sales: Revenue generated from manufacturing and selling pharmaceutical products including injectables, syrups, creams, ointments, and suppositories to domestic pharmacies, hospitals, and healthcare institutions

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

Core offering

Caspian Tamin Pharmaceutical Co. is a GMP-certified Iranian pharmaceutical manufacturer that produces and sells a portfolio of generic and specialty medications across 13 therapeutic categories, with a strategic focus on injectable pharmaceutical products including ampoules, vials, and pre-filled syringes. The company manufactures muscle relaxants, neuromuscular blockade reversal agents, immunomodulators for multiple sclerosis, cardiovascular, analgesic, corticosteroid, antibacterial, nutritional supplement, and dermatological products from its 150,000 sqm facility in Rasht Industrial City, Gilan Province, distributing through pharmacy networks, hospitals, and export operations.

Product overview

Caspian Tamin Pharmaceutical Co. is an Iranian pharmaceutical manufacturer specializing in injectable pharmaceutical products. The company produces a diverse portfolio of generic and specialty medications organized into 13 therapeutic categories: Analgesics/Anti-inflammatory, Antimyasthenic/Muscle Relaxants, Hormonal/Anabolic Drugs, Antihistamine/Bronchodilators, Cardiovascular/Homeostatic, Corticosteroids, Antibacterials, Gastrointestinal, Antagonists, Nutritional Supplements/Vitamins, Dermatological, Antifungals, and Immunomodulators. The product portfolio includes injectables (ampoules, vials), pre-filled syringes, oral solutions, suppositories, and topical formulations (creams, ointments, gels). Key products include Caspiramer (glatiramer acetate for MS), Casmeron (rocuronium bromide muscle relaxant), Sugammadex (neuromuscular blockade reversal agent), and various cardiovascular, analgesic, and nutritional supplement products. The company operates GMP-compliant manufacturing facilities in Rasht Industrial City, Gilan Province, and operates under WHO guidelines. Key therapeutic focus areas include neuromuscular blocking agents and their reversal, immunomodulation for autoimmune diseases, and injectable pharmaceutical formulations.

Differentiator

Problem solved

Functional benefit

Brands

• Casmeron: Brand name for Rocuronium Bromide muscle relaxant product

Products and services

• Casmeron (Rocuronium Bromide) Non-depolarizing muscle relaxant used for rapid sequence intubation (RSI), with onset of 45-60 seconds at lower doses and 30-60 minutes duration. Available in 50mg/5mL and 100mg/10mL ampoule formulations for anesthesiologists, surgeons, and emergency physicians.
• Sugammadex Injection Reversal agent for neuromuscular blockade induced by rocuronium bromide. Administered as an IV bolus (200mg/2mL) for immediate reversal in adults and children 2 years and older. Caspian Tamin is the first Iranian manufacturer of this product.
• Caspiramer (Glatiramer Acetate) Immunomodulator containing glatiramer acetate for treatment of relapsing forms of multiple sclerosis (MS), including clinically isolated syndrome, relapsing-remitting, and active secondary progressive forms. Administered subcutaneously three times weekly for patients with relapsing MS.
• Succinylcholine Chloride Injection Depolarizing muscle relaxant for rapid sequence intubation, available in 500mg/10mL ampoule formulation. Used by anesthesiologists and emergency physicians for surgical procedures requiring rapid muscle relaxation.
• Diltiazem HCl 2% Gel Topical gel formulation of diltiazem hydrochloride for dermatological applications. Used for transdermal drug delivery in cardiovascular and topical therapy contexts.
• Daladic 300 Pharmaceutical product in the nutritional supplements and vitamins category, distributed through pharmacy networks.
• Daladic 600 Pharmaceutical product in the nutritional supplements and vitamins category, distributed through pharmacy networks.
• Dexadic Pharmaceutical product in the analgesics, anti-inflammatory, and antipyretic category, distributed through pharmacy networks.
• Dexpanthenol 500mg Nutritional supplement product containing dexpanthenol, distributed through pharmacy networks.
• Dopadic Pharmaceutical product in the cardiovascular category, distributed through pharmacy networks.
• Dithrecol Pharmaceutical product in Caspian Tamin's portfolio, distributed through pharmacy networks.
• Dimin-Ject Pharmaceutical product in the immunomodulators category, distributed through pharmacy networks.

Segments1 record

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Three partnerships are on record, tiered major and minor.

• Daroupakhsh Co.majorChannel Partner/ Reseller/ DistributorKey distribution partner representing one of the board members. Daroupakhsh Co. serves as a major distribution channel for Caspian Tamin's pharmaceutical products in the Iranian market.
• Pars Daru CompanymajorChannel Partner/ Reseller/ DistributorPharmaceutical distribution company represented on the board of directors, serving as a key channel partner for product distribution.
• Hejrat Broadcasting CompanyminorStrategic or Co-development PartnerCorporate shareholder represented on the board of directors.

Scale indicators3 records

Recent moves8 records

Expansion highlights5 records

Broad incumbents

• Cipla: Large Indian-headquartered global generic pharmaceutical company with a significant injectables portfolio across respiratory, anesthesia, and specialty categories, comparable to Caspian Tamin on injectable generics and emerging-market export orientation.
• Hikma Pharmaceuticals: Jordan-headquartered multinational generic and injectable pharmaceutical manufacturer with deep Middle East distribution, serving as a larger incumbent competing in many of the same therapeutic categories and MENA export channels that Caspian Tamin targets.
• Dr. Reddy's Laboratories: Global Indian generic and specialty pharmaceutical manufacturer with strong sterile injectables and biosimilar capabilities, comparable to Caspian Tamin on the manufacturing of complex injectable molecules and on emerging-market commercial reach.
• Fresenius Kabi: Global leader in sterile injectables, infusion solutions, and specialty pharmaceuticals, representing a much larger incumbent that competes in the injectable and specialty pharma categories where Caspian Tamin's Sugammadex, rocuronium, and Caspiramer franchises operate.

Direct peers

• Sobhan Oncology: Iranian specialty pharmaceutical manufacturer focused on oncology and complex injectables, comparable to Caspian Tamin on the ability to manufacture higher-complexity sterile products within Iran's regulatory framework.
• Shafa Pharmaceutical Company: Iranian manufacturer of injectable and other pharmaceutical dosage forms, competing directly with Caspian Tamin in the domestic injectable generics market and sharing similar GMP/WHO-aligned positioning.
• Tofigh Daru Pharmaceutical Company: Iranian pharmaceutical manufacturer producing injectables and specialty products, comparable to Caspian Tamin as a domestic peer in injectable generics and specialty sterile manufacturing.
• Barakat Pharmaceutical Group: Large Iranian pharmaceutical holding group with broad generic and specialty manufacturing operations across multiple dosage forms, directly comparable as a domestic Iranian pharma manufacturer competing in the same regulatory and pricing environment.
• Zahravi Pharmaceutical Company: Iranian pharmaceutical manufacturer focused on injectables and sterile products, comparable to Caspian Tamin on dosage form specialization (sterile injectables), domestic market positioning, and GMP-based exports.
• Darou Pakhsh Pharma Manufacturing Company: Major Iranian generic pharmaceutical manufacturer producing injectables and other dosage forms, sharing the same domestic Iranian market, GMP manufacturing model, and TPICO-affiliated ownership network as Caspian Tamin.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/caspian-tamin-pharmaceutical-co.
• Instagraminstagram.com/caspiantamin_pharma_

Compliance7 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Caspian Tamin Pharmaceutical Co.